Latest News & Updates

Breaking News

  • 4 hours ago

  • Vaibhavi M.

Amneal Introduces Bimatoprost Ophthalmic Solution To Treat Glaucoma And Ocular Hypertension
Breaking News
Telix’s Pixclara NDA Accepted By US FDA, Review Underway For Glioma Imaging Agent With September 2026 Decision Timeline

Vaibhavi M.

Other trending news you may like to read

Amneal Introduces Bimatoprost Ophthalmic Solution To Treat Glaucoma And Ocular Hypertension

Amneal Pharmaceuticals launches bimatoprost ophthalmic solution 0.01%, a generic of Lumigan, to treat open-angle glaucoma and ocular hypertension in the US market.

Vaibhavi M.

Pharma Now

Telix’s Pixclara NDA Accepted By US FDA, Review Underway For Glioma Imaging Agent With September 2026 Decision Timeline

Telix Pharmaceuticals Limited NDA for Pixclara (TLX101-Px) accepted by FDA for glioma imaging, with PDUFA date set for September 2026 to support brain cancer diagnosis.

Vaibhavi M.

Pharma Now

Glenmark Secures US FDA Approval For Progesterone Vaginal Inserts, Expands Presence In $59.2 Million Market

Glenmark Pharmaceuticals Limited secures FDA approval for progesterone vaginal inserts 100 mg, a generic of Endometrin, to treat infertility-related conditions in women’s health.

Vaibhavi M.

Pharma Now

ANI Pharmaceuticals Launches Generic Isosorbide Mononitrate Tablets For Angina Treatment, Following FDA Approval

ANI Pharmaceuticals launches generic Isosorbide Mononitrate tablets for angina treatment following FDA approval, expanding access to affordable nitrate therapy options.

Vaibhavi M.

Pharma Now